Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy
Part of paid clinical trials in Englewood, New Jersey.
- Sponsor
- Englewood Hospital and Medical Center
- Study ID
- NCT06681818
- Status
- Recruiting
Conditions
- Liver Cancer Adult
- Liver Regeneration
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- carbon monoxide measurement via smokerlyzer — OTHERparticipants in this study will provide breath samples for carbon monoxide measurements pre and post liver resection
Study Details
the investigators will pursue two specific aims: (1) to monitor the extent of heme oxygenase induction (by measuring endogenous CO production) in relationship to the extent of hepatic resection (2) to assess the production of CO in patients following liver resection and correlate these findings to the rate of liver regeneration and liver function.
Key Dates
- Start date
- Nov 21, 2025
- Status verified
- Nov 2024
- Primary completion
- Jan 1, 2039
- Completion
- Jan 1, 2039
Study Design
- Enrollment
- 125 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: all participantsall participants will provide breath samples to detect carbon monoxide levels
Primary Outcome Measure
correlation of carbon monoxide levels in exhaled breath with quantity and quality of liver regeneration [ Time Frame: measurements will be taken pre, then 4 hours and 24 hours post resection ]
Central Contacts
- Jamie Ketas2018943418
- Raquel Molina
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Englewood Hospital | Englewood | New Jersey | 07631 | Raquel Molina |
Find similar trials in Englewood, NJ
By research site